US 8207170
Heterocyclic substituted piperazines with CXCR3 antagonist activity
granted A61PA61P1/04A61P17/06
Quick answer
US patent 8207170 (Heterocyclic substituted piperazines with CXCR3 antagonist activity) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/00, A61P19/02